Ebdrup, B H
'No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia': authors' response. [electronic resource]
- Acta psychiatrica Scandinavica 11 2017
- 526-527 p. digital
Publication Type: Letter; Research Support, Non-U.S. Gov't; Comment
1600-0447
10.1111/acps.12795 doi
Antipsychotic Agents
Glucagon-Like Peptide-1 Receptor
Humans
Obesity
Schizophrenia